https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Cell-MC.jpg

Orthopedic Bone Graft Substitutes Market Analysis | United States | 2019-2025 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Pages: 589
  • Published Date: 3/1/2017
  • Type: MedCore

The allograft market has gained more interest in recent years resulting in slight growth in units, but this growth is offset by the declining ASP. This is due to hospitals encouraging more cost-effective procedures by using more allograft rather than the more expensive DBM and synthetic products. Nevertheless, the growth in both DBM and synthetic materials will outpace any resurgence of growth in allograft in terms of units sold. This results in the allograft market remaining the smallest segment in the overall bone graft substitute market.

Bone is a biologically active tissue and will regenerate whenever possible; however, there are instances where the damage is significant enough to warrant a scaffold to help rejoin the fissure or cavity. Bone grafting is a surgical procedure in which damaged bone is replaced with autograft tissue, allograft tissue or a bone graft substitute, which can be either synthetic or metal.

Segments Covered in This Market

  • Allograft Bone Graft Substitute Market
  • Synthetic Bone Graft Subsitute Market
  • Demineralized Bone Matrix Allograft Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Medtronic led the total bone graft substitute market in 2016. This was due to a leading share in the demineralized bone graft market and placing second in the fast growing synthetic bone graft market. DePuy Synthes was second in the total bone graft substitute market in 2016. This was achieved from placing second in the demineralized bone graft market and third in the synthetic bone graft market. Stryker was third in the bone graft substitute market in 2016, which was achieved from a leading share in the synthetic bone graft market. Styker was the leader in the fast growing synthetic graft segment. Other companies analyzed include SeaSpine, Zimmer Biomet, RTI Surgical, Wright Medical, Muscoskeletal Transplant Foundation (MTF), Allosource, Baxter, Xtant International, LifeNet Health, Bioventus, Biocomposites, Arthrex, Exactech and Alphatec Spine.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled U.S. Market Report Suite for Orthopedic Biomaterials – MedSuite

Learn More about these product types
 

FREE Sample Report



The "US Market Report Suite for Orthopedic Biomaterials 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Medtronic
Genzyme
DePuy Synthes
Anika Therapeutics
Ferring Pharmaceuticals
Stryker
NuVasive
Bioventus
Zimmer Biomet
Integra LifeSciences
RTI Surgical
Fidia Pharmaceuticals
MTF
Orthofix
Arthrex
AlloSource
Aastrom
Baxter
Harvest Technologies
Wright Medical
Bacterin International
Arteriocyte
Exactech
LifeNet Health
Biocomposites
Alphatec Spine
Celling Biosciences
Globus Medical
Nuo Therapeutics
K2M
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology